|
Catalogue
Number
|
Product
|
Order number / Unit
|
|
|
2061
|
(R)-(+)-Normethylcarbamoyl-GR 103545
|
2061.0001: 1 mg per vial
2061.0003: 3 mg per vial
2061.0010: 10 mg per vial
Please inquire for customized
filling and bulk quantities.
|
|
|
Precursor for (S)-(+)-[11C]-GR 103545
|
|
|
|
|
|
|
|
|
Molar Mass: 356.29
|
|
|
C17H23Cl2N3O
|
|
|
[199470-02-5]
|
|
|
|
|
|
Yellowish oil packaged in dark glass crimp cap vials.
|
|
|
|
|
|
|
|
|
Purity: > 95 %
|
|
|
Certificates:
CoA; 1H and 13C NMR spectra
|
|
|
Chemical Name:
CA index name: Piperazine, 1-[(3,4-dichlorophenyl)acetyl]-2-(1-pyrrolidinylmethyl)-, (2R)
|
|
|
Synonymes:
(2R)-2-(3,4-Dichlorophenyl)-1-(2-pyrrolidin-1-ylmethyl-piperazine-1-yl)-ethanon; (2R)-1-[(3,4-Dichlorophenyl)acetyl]-2-(1-pyrrolidinymethyl)piperazine
|
|
|
Literature:
Ravert H.T. et al. [11C]-GR 89696, a potent kappa opiate receptor radioligand; in vivo binding of the R and S enantiomers. Nuc. Med. Biol. 2002, 29, 47-53.
|
|
|
Talbot P.S. et al. 11C-GR 103545, a Radiotracer for Imaging κ-Opioid Receptors In Vivo with PET: Synthesis and Evaluation in Baboons. J. Nucl. Med. 2005, 46, 484-494.
|
|
|
Naylor A. et al. A Potent New class of κ-Receptor Agonist: 4-Substituted 1-(Arylacetyl)-2-[(dialkylamino)methyl]piperazines. J. Med. Chem. 1993, 36, 2075-2083.
|
|
|
Schoultz B.W. et al. A New Method for Radiosynthesis of 11C-Labeled Carbamate Groups and its Application for a Highly Efficient Synthesis of the Kappa-Opioid Receptor Tracer [11C]GR 103545. The Open Med. Chem. J. 2008, 2 ,72-74.
|
|
|
|
|
|
date of product catalogue issue:
10 May 2017
|